Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: J Consult Clin Psychol. 2018 Jul;86(7):615–630. doi: 10.1037/ccp0000315

Table 4.

Participant-level EPCS-rated fear change metrics predicting treatment outcome

OCD Symptom SeverityΔa Global Improvementb Treatment Responsec
Fear change Metric (slope) Estimate SE t(df) 95% CI Estimate SE t(df) 95% CI Estimate SE t(df) 95% CI
Habituation 1.85 0.69 2.69(103) 3.21, −0.48 0.28 0.11 2.64(103) 0.49, −0.07 0.54 0.22 2.44(102) 0.10,0.98
Non-habituation fear decreases −0.19 0.76 −0.24(103) −1.69, 1.32 0.01 0.11 0.09(102) −0.23, 0.23 −0.02 0.22 −0.09(102) −0.45, 0.41
Fear increases 0.11 0.67 0.17(103) −1.23, 1.44 −0.01 0.09 −0.11(102) −0.20,0.18 −0.05 0.19 −0.23(102) −0.43, 0.34
Fear changes −0.39 0.61 −0.64(103) −1.60,0.82 −0.11 0.09 −1.21(102) −0.27, 0.07 0.10 0.17 0.61(102) −0.24, 0.44
Exposures ending at zero fear −0.29 1.18 −0.24(103) −2.62, 2.05 −0.23 0.18 −1.23(102) −0.59,0.14 0.09 0.36 0.24(102) −0.62, 0.79
Peak – End fear −1.06 1.23 −0.86(97) −3.50, 1.39 −0.12 0.18 −0.68(96) −0.47, 0.47 0.33 0.35 0.94(96) −0.37, 1.03
Peak fear 0.71 0.92 0.77(104) −1.11,2.53 0.20 0.14 1.46(103) −0.08, 0.55 −0.33 0.27 −1.22(103) −0.87, 0.42
Number exposures −1.23 0.96 −1.28(102) −3.15,0.68 −0.28 0.14 −2.03(101) −0.55, −0.01 0.36 0.27 1.35(101) −0.17,0.90
Duration exposures −0.55 0.72 −0.77(102) −1.97,0.87 −0.13 0.10 −1.29(101) −0.33, 0.07 0.21 0.20 1.09(101) −0.17,0.60

p < .05 (Holm-adjusted across outcomes);

Significant difference between model predicted and actual values for participants with predictor value of zero;

a

CYBOCS change baseline to post-treatment (lower values indicate greater symptom reduction);

b

CGI-I post-treatment (lower values indicate greater global improvement);

c

Treatment Responder (higher values indicate greater odds of treatment response)